CompletedNot Applicable

Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)

Norway74 participantsStarted 2013-12

Plain-language summary

The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participant in one of two former studies and heart transplanted at the time of inclusion into this former study Exclusion Criteria: * Cognitively not capable to consent to participation and/or * Insufficient fluent in the Norwegian language to complete both psychiatric and neuropsychological assessment

What they're measuring

Psychiatric morbidity

Timeframe: At time of enrollment

Cognitive function

Timeframe: At time of enrollment

Trial details

NCT IDNCT02035865

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-11

View on ClinicalTrials.gov More Psychiatric Diagnosis trials